首页> 美国卫生研究院文献>BMC Cancer >Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study
【2h】

Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study

机译:明确放化疗治疗胸腔食管鳞状细胞癌侵犯邻近器官的食管瘘危险因素:单中心病例对照研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundStandard treatment for unresectable esophageal squamous cell carcinoma (ESCC) without distant metastasis is definitive chemoradiotherapy (dCRT), in which the incidence of esophageal fistula (EF) is reported to be 10–12%. An ad hoc analysis of JCOG0303, a phase II/III trial of dCRT for patients with unresectable ESCC (including non-T4b), suggested that esophageal stenosis is a risk factor for EF. However, risk factors for EF in patients limited to T4b ESCC treated with dCRT have yet to be clarified. The aim of this study was to investigate risk factors for EF in T4b thoracic ESCC treated with dCRT.
机译:背景技术对于不能切除,无远处转移的食管鳞状细胞癌(ESCC)的标准治疗是定性放化疗(dCRT),据报道,其中食管瘘(EF)的发生率为10–12%。 JCOG0303的一项临时分析(dCRT的II / III期临床试验针对无法切除的ESCC(包括非T4b)患者)表明,食管狭窄是EF的危险因素。但是,仅限于接受dCRT治疗的T4b ESCC患者的EF危险因素尚未阐明。这项研究的目的是调查经dCRT治疗的T4b胸ESCC中EF的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号